Our October Newsletter Highlights: š¹ Scientific poster accepted at AACR Ovarian Cancer Conference š¹ Strategic partnership signed with Prestige Biopharma for pancreatic cancer š¹ Imagion
Highlights: Reduces operating expenses Update on MagSenseĀ® HER2 program MELBOURNE ā Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier
SINGAPORE, and San Diego, California – Prestige Biopharma,Ā a biopharmaceutical company specializing in innovative antibody therapies, with a strong dedication to tackling pancreatic cancer, and Imagion
Highlights include: MagSenseĀ®Ā HER2 Phase 1 Study achieves enrolment target Expands collaboration with Siemens Healthineers Dr. Isaac Bright appointed as CEO MELBOURNE ā Imagion Biosystems (ASX:IBX),
MELBOURNE ā Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce it has
Highlights Study achieves enrolment target Study to formally close to new enrolments on 31 July Study results support further clinical development as MRI imaging agent
Australasian Biotechnology | Vol 33 Number 1 Imagion authored a white paper, published in the April issue of Australasian Biotechnology, discussing current medical imaging technologies,
Imagion Biosystems’ Chairmanās address to shareholders at the 2023 Annual General Meeting. PDF of the 2023 AGM Presentation Deck Watch the AGM 2023 Q&A Session
Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting
MELBOURNE ā Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, announces it has initiated plans to separate the
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
Ā© Imagion Biosystems, Ltd. All Rights Reserved |Ā Privacy PolicyĀ |Ā Terms & Conditions | Careers | Corporate Governance